…Metabolic dysfunction-associated steatohepatitis (MASH) is a multifactorial metabolic liver disease that occurs …
MASH
This disease is selected. Its supporting articles are shown below.
Articles mentioning MASH
28 articles · page 2 of 3…aracterised the severity, persistence and impact of pruritus in PBC, PSC, chronic hepatitis B or C virus infection (HBV/HCV), drug-…
…ibrosis, and improvement in liver fibrosis with no worsening of steatohepatitis.A secondary analysis of part 1 evaluated treatment response thr…
…ox/flox) mice were fed either a low-fat control diet (CTL) or a MASH ‘Fast Food’ diet (Western diet with 21% milk fat, 1.25% cholest…
…Introduction Hepatocellular carcinoma (HCC) is a leading cause of cancer-related deaths worldwide. Me…
…n early marker of disease progression. IH was notably higher in MASH than in MASL, resulting in higher IH/DR ratios.Conclusion Speci…
…patitis (MASH), which is linked to cirrhosis, liver failure and hepatocellular carcinoma. The recent approval of resmetirom and semaglutide1 2 for activ…
…Metabolic dysfunction-associated steatotic liver disease (MASLD) has become the most prevalent chronic liver disease worldwide a…
…Metabolic dysfunction-associated steatotic liver disease (MASLD) and its inflammatory progression to metabolic dysfuncti…
… to ArLD (AAPC 3.28), liver cancer due to HepB (AAPC 3.17), and liver cancer due to HepC (AAPC 3.14). In regard to the ASDR, a statistically…
… (p=0.046).Conclusion Patients without or with cirrhosis due to MASLD treated with resmetirom experience sustained improvement in sel…